153 related articles for article (PubMed ID: 7990538)
1. [What is the connection between Parkinson disease and tardive dyskinesia?].
Gunne LM; Andrén PE
Lakartidningen; 1994 Aug; 91(34):2953-5. PubMed ID: 7990538
[No Abstract] [Full Text] [Related]
2. Tardive dyskinesia.
Gerlach J
Dan Med Bull; 1979 Aug; 26(5):209-45. PubMed ID: 40756
[No Abstract] [Full Text] [Related]
3. Animal models of tardive dyskinesia--a review.
Kulkarni SK; Naidu PS
Indian J Physiol Pharmacol; 2001 Apr; 45(2):148-60. PubMed ID: 11480221
[TBL] [Abstract][Full Text] [Related]
4. Tardive dyskinesia: a biological appraoch.
Barbaccia ML; Trabucchi M
Prog Clin Biol Res; 1980; 39():181-93. PubMed ID: 6105670
[No Abstract] [Full Text] [Related]
5. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
Rondot P; Bathien N
Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446
[No Abstract] [Full Text] [Related]
6. Current psychopathological theories of tardive dyskinesia and their implications for future research.
Ananth J
Neuropsychobiology; 1982; 8(4):210-22. PubMed ID: 6127649
[TBL] [Abstract][Full Text] [Related]
7. Tardive dyskinesia: pathophysiology and animal models.
Casey DE
J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
[TBL] [Abstract][Full Text] [Related]
8. [Tardive dyskinesias. Epidemiology and physiopathology].
Gerlach J
Ugeskr Laeger; 1987 Jun; 149(25):1678-81. PubMed ID: 2885954
[No Abstract] [Full Text] [Related]
9. [Tardive dyskinesia].
Sabbatini F; Gentile S; De Mattei M; Pinessi L; Rainero I
Minerva Med; 1985 Apr; 76(16):797-802. PubMed ID: 2860619
[TBL] [Abstract][Full Text] [Related]
10. [Tardive dyskinesia--research results and preventive measures].
Gunne LM
Lakartidningen; 1987 Apr; 84(17):1458-63. PubMed ID: 3586787
[No Abstract] [Full Text] [Related]
11. Treatment of tardive dyskinesia.
Hollister LE
Curr Psychiatr Ther; 1980; 19():89-97. PubMed ID: 6109597
[No Abstract] [Full Text] [Related]
12. [Physiopathology and curative treatment of tardive dyskinesia].
Wolf MA; Gautier J
Encephale; 1987; 13(5):301-8. PubMed ID: 2892663
[TBL] [Abstract][Full Text] [Related]
13. Is there a presynaptic tardive dyskinesia?
Bowers MB; Glazer WM
J Clin Psychopharmacol; 1987 Feb; 7(1):57-9. PubMed ID: 2880877
[No Abstract] [Full Text] [Related]
14. Epidemiology and pathophysiology of tardive dyskinesias.
Klawans HL; Tanner CM; Goetz CG
Adv Neurol; 1988; 49():185-97. PubMed ID: 2894124
[No Abstract] [Full Text] [Related]
15. Biochemical methods for predicting the occurrence of tardive dyskinesia.
Bürki HR
Commun Psychopharmacol; 1979; 3(1):7-15. PubMed ID: 38033
[No Abstract] [Full Text] [Related]
16. Drug therapy of tardive dyskinesia.
Kobayashi RM
N Engl J Med; 1977 Feb; 296(5):257-60. PubMed ID: 12469
[No Abstract] [Full Text] [Related]
17. Tardive dyskinesia: a role for the endogenous opioid system.
Sandyk R
Med Hypotheses; 1986 Jan; 19(1):71-4. PubMed ID: 2871480
[TBL] [Abstract][Full Text] [Related]
18. New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable.
Hadj Tahar A; Grondin R; Grégoire L; Calon F; Di Paolo T; Bédard PJ
Adv Neurol; 2003; 91():51-64. PubMed ID: 12442663
[No Abstract] [Full Text] [Related]
19. Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
Mela F; Marti M; Dekundy A; Danysz W; Morari M; Cenci MA
J Neurochem; 2007 Apr; 101(2):483-97. PubMed ID: 17359492
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic-induced supersensitivity psychosis, the "hump course," and tardive dyskinesia.
Chovinard G; Jones B
J Clin Psychopharmacol; 1982 Apr; 2(2):143-4. PubMed ID: 6122695
[No Abstract] [Full Text] [Related]
[Next] [New Search]
